Original language | English |
---|---|
Article number | e105179 |
Journal | PLoS ONE |
Volume | 9 |
Issue number | 7 |
DOIs |
|
State | Published - 31 Jul 2014 |
Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)
M. Burotto, J. Wilkerson, W. Stein, R. Motzer, S. Bates
Research output: Contribution to journal › Comment/debate